Aaron A. Ondrey

Aaron A. Ondrey is recorded as CFO and Chief Accounting Officer at Syndax Pharmaceuticals Inc (SNDX) since November 9, 2026. Syndax Pharmaceuticals Inc reported in an 8-K filed November 2, 2026 that Aaron A. Ondrey was appointed treasurer, effective November 9, 2026. Syndax Pharmaceuticals Inc reported in an 8-K filed November 2, 2026 that Aaron A. Ondrey was appointed principal accounting and financial officer, effective November 9, 2026. Syndax Pharmaceuticals Inc reported in an 8-K filed November 2, 2026 that Aaron A. Ondrey was appointed Chief Financial Officer, effective November 9, 2026. Syndax Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Syndax Pharmaceuticals Inc includes Michael A. Metzger (CEO and Board Member), Michael Metzger (CEO), Daphne Karydas (CFO) and 5 others.